MedtechVision 2017: The Evolution of Medtech
Join us on September 12th for the seventh annual MedtechVision conference.
Tuesday, September 12, 2017
2825 Sand Hill Rd
Menlo Park, CA 94025
2017 Theme Description: The Evolution of Medtech
The medtech sector has been in flux in recent years. Corporate consolidation, pricing pressure, rising regulatory requirements and salesforce constraints have all played a role. Venture funding for medtech is out of favor, perhaps for good, leading some to conclude that “medtech is dead”. Simultaneously, new innovations and new entrants have emerged from the tech and retail sectors that may represent competition or opportunity for medtech to take advantage of data, connectivity and partnerships that will enable medtech to reinvent itself. The conference will approach this debate head on with examples of where traditional medtech is alive and well and where it has faltered alongside examples of where the new opportunities have been successful and where they have failed and why.
Welcome & Introduction
Panel 1: Debate – Is Medtech Dead?
Moderator: Nada Hanafi, Chief Strategy Officer, Experien Group
Panel 2: New Entrants – Friends of Foe?
Moderator: Amanda DePalma, VP of Global Marketing, Endologix
Moderator: Susan Stimson, General Manager, Intersect ENT
Panel 3: Smart Devices – Medtech & Data
Moderator: Leslie Oley, Head of Product & Growth, Evidation Health
Panel 4: Enabling New Care Paradigms – Outside the Clinic Walls
Moderator: Stacey Pugh, VP and General Manager, Medtronic Neurovascular
End of day Keynote – Deborah DiSanzo, General Manager for IBM Watson Health
Networking Wine Reception & Dinner